United Therapeutics (UTHR) Cash from Operations Growth (1y) (2010 - 2026)
United Therapeutics (UTHR) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 0.46% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 425.00% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 450.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.46% |
| Dec 31, 2025 | 1.47% |
| Sep 30, 2025 | 49.02% |
| Jun 30, 2025 | -17.44% |
| Mar 31, 2025 | 22.50% |
| Dec 31, 2024 | 126.41% |
| Sep 30, 2024 | 8.95% |
| Jun 30, 2024 | 118.44% |
| Mar 31, 2024 | 0.45% |
| Dec 31, 2023 | 17.55% |
| Sep 30, 2023 | 33.87% |
| Jun 30, 2023 | -16.30% |
| Mar 31, 2023 | 29.82% |
| Dec 31, 2022 | -26.58% |
| Sep 30, 2022 | 39.33% |
| Jun 30, 2022 | -14.30% |
| Mar 31, 2022 | 221.49% |
| Dec 31, 2021 | 38.35% |
| Sep 30, 2021 | -26.03% |
| Jun 30, 2021 | -9.63% |